J&J starts clinical trial of Ebola vaccine in Sierra Leone

FREETOWN - Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone. Trial recruitment is underway and the first volunteers have received their initial vaccine dose, the company said in a statement. This is the first study conducted of Janssen's Ebola prime-boost vaccine regimen in a West African country affected by the recent Ebola epidemic, J&J said. -Reuters